Combined with previous loss of function studies [39], our results are consistent with the hypothesis that Plastin 3 and its C. elegans ortholog are cross-species modifiers of locomotion defects in SMA models. The gene discussed is PLS3; the disease is proximal spinal muscular atrophy.